Form 4: Omada Health CEO Sean P. Duffy Granted Significant Restricted Stock Units

Omada Health, Inc. CEO and Director Sean P. Duffy has been granted 144,736 restricted stock units (RSUs) as part of his compensation, aligning his interests with long-term company performance.

Summary

• Sean P. Duffy, Chief Executive Officer and Director of Omada Health, Inc. (OMDA), was granted 144,736 restricted stock units (RSUs) on June 5, 2025.
• These RSUs entitle Mr. Duffy to receive one share of Common Stock for each RSU upon vesting, with a transaction price of $0, indicating a grant rather than a purchase.
• The RSUs will vest quarterly, with 1/16th vesting on each quarterly anniversary starting from June 5, 2025, leading to 100% vesting on the fourth anniversary of this date.
• Following this transaction, Mr. Duffy directly beneficially owns 144,736 shares (RSUs) and indirectly owns 861,109 shares held in family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects a standard executive compensation practice that aligns the CEO's interests with long-term company performance and shareholder value. It indicates stability in leadership and a commitment to retention.

Positives

• The grant of 144,736 Restricted Stock Units (RSUs) to CEO Sean P. Duffy aligns his compensation directly with the long-term performance and shareholder value creation of Omada Health, Inc.
• The vesting schedule over four years encourages executive retention and sustained focus on strategic objectives.
• The transaction indicates continued commitment and confidence from the company's board in its Chief Executive Officer.

Negatives

• No negative aspects are directly discernible from this Form 4 filing, as it primarily reports a routine executive compensation grant.

Risks

• The value of the granted RSUs is contingent on the future stock price performance of Omada Health, Inc., exposing the compensation to market fluctuations.
• The long vesting period means the executive's full compensation from this grant is dependent on continued employment and company performance over four years.

Future Outlook

The grant of Restricted Stock Units with a four-year vesting schedule indicates a long-term commitment from the company to its CEO and aligns his future compensation with the company's sustained performance and growth over this period.

Industry Context

The grant of Restricted Stock Units (RSUs) is a common form of executive compensation in the technology and healthcare sectors, particularly for growth-oriented companies like Omada Health. This practice aims to incentivize long-term performance and retain key leadership by tying their personal wealth to the company's stock performance.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a significant component of executive compensation is standard practice across the healthcare technology industry, including companies like Teladoc Health, Livongo (acquired by Teladoc), and Amwell, which frequently utilize equity grants to align executive interests with shareholder value.
• A four-year vesting schedule, with quarterly increments, is a typical structure for RSU grants in the U.S. market, comparable to practices at companies such as Google (Alphabet), Microsoft, and other major tech firms, designed to ensure long-term retention and performance incentives.

Related Party Transactions

• Sean P. Duffy indirectly beneficially owns 861,109 shares held in family trusts for the benefit of his family members. He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: The RSU grant aligns the CEO's financial interests with the company's long-term stock performance, potentially benefiting shareholders through incentivized growth and value creation.
• Employees: The stability of leadership, reinforced by long-term equity incentives, can contribute to a more stable and focused corporate environment.

Next Steps

• The Restricted Stock Units (RSUs) will vest quarterly, with 1/16th of the units vesting on each quarterly anniversary of June 5, 2025, until fully vested on the fourth anniversary.

Key Dates

Keywords

Omada Health, OMDA, Sean P. Duffy, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Equity Grant, Corporate Governance